Skip to main content

International Journal of Hematology

Ausgabe 5/2020

Inhalt (24 Artikel)

Stealth thrombosis of brain and kidney in a girl with Upshaw–Schulman syndrome not receiving prophylactic plasma infusions

  • Images in Hematology

Saori Tanabe, Yoshihiro Fujimura, Bernhard Lämmle, Toshiyuki Kimura, Ayami Isonishi, Kazuya Sakai, Masanori Matsumoto

Auer-bodies in cellular components other than typical myeloblasts

  • Images in Hematology

Tohru Inaba, Taku Tsukamoto, Naohisa Fujita, Junya Kuroda

Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation

  • Rapid Communication

Fumiya Wada, Momoko Nishikori, Masakatsu Hishizawa, Mitsumasa Watanabe, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu, Takero Shindo, Tadakazu Kondo, Akifumi Takaori-Kondo

Expert consensus regarding standardization of sample preparation for clotting time assays

  • Guideline

Masahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, Hisako Katagiri, Chisato Shimazu, Sumiyoshi Naito, Masato Matsuda, Yoichi Yuki, Kazuyoshi Miyata, Rika Arai, Osamu Kumano, Mari Emmi, Tatsuya Yoshida, Hideaki Tanaka, Toshihiko Okuhara, Tetsuji Yamashita, Yasuji Sekine, Masaru Homma, Yohko Kawai, Kaoru Tohyama, Masahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, Hisako Katagiri, Chisato Shimazu, Sumiyoshi Naito, Masato Matsuda, Yoichi Yuki, Kazuyoshi Miyata, Rika Arai, Osamu Kumano, Mari Emmi, Tatsuya Yoshida, Hideaki Tanaka, Toshihiko Okuhara, Tetsuji Yamashita, Yasuji Sekine, Masaru Homma, Yohko Kawai, Kaoru Tohyama

A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X

  • Original Article

Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto, Mariko Noguchi-Sasaki, Michinori Hirata, Tetsuhiro Soeda, Midori Shima

Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients

  • Original Article

Yanika Jindamai, Ekarat Rattarittamrong, Arintaya Phrommintikul, Lalita Yongsmith, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Adisak Tantiworawit, Lalita Norasetthada

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

  • Original Article

Naoki Takezako, Hiroshi Kosugi, Morio Matsumoto, Shinsuke Iida, Takayuki Ishikawa, Yukio Kondo, Kiyoshi Ando, Hirokazu Miki, Itaru Matsumura, Kazutaka Sunami, Takanori Teshima, Hiromi Iwasaki, Yasushi Onishi, Masahiro Kizaki, Koji Izutsu, Dai Maruyama, Kensei Tobinai, Razi Ghori, Mohammed Farooqui, Jason Liao, Patricia Marinello, Kenji Matsuda, Yasuhiro Koh, Takashi Shimamoto, Kenshi Suzuki

Development of diffuse large B-cell lymphoma from duodenal type follicular lymphoma: a retrospective study of 23 cases

  • Original Article

Masuho Saburi, Yoshiyuki Kondo, Masao Ogata, Yasuhiro Soga, Miyuki Abe, Kuniko Takano, Kazuhiro Kohno, Takayuki Nagai, Toshiyuki Nakayama

Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry

  • Original Article

Aya Nakaya, Hirokazu Tanaka, Hideo Yagi, Kensuke Ohta, Hirohiko Shibayama, Takae Kohara, Junya Kanda, Maki Shindo, Yuji Shimura, Satoru Kosugi, Toru Kida, Hitomi Kaneko, Kazunori Imada, Takahiro Karasuno, Mitsuhiro Matsuda, Masato Iida, Yoko Adachi, Shin-ichi Fuchida, Nobuhiko Uoshima, Hitoji Uchiyama, Ryoichi Takahashi, Toshimitsu Matsui, Katsuya Wada, Miki Kiyota, Chihiro Shimazaki, Masayuki Hino, Junya Kuroda, Yuzuru Kanakura, Akifumi Takaori-Kondo, Shosaku Nomura, Itaru Matsumura

Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory Hodgkin lymphoma: a multicenter retrospective study

  • Original Article

Ayumu Ito, Sung-Won Kim, Ken-ichi Matsuoka, Toshiro Kawakita, Takashi Tanaka, Yoshihiro Inamoto, Tomomi Toubai, Shin-ichiro Fujiwara, Masafumi Fukaya, Tadakazu Kondo, Junichi Sugita, Miho Nara, Yuna Katsuoka, Yosuke Imai, Hideyuki Nakazawa, Ichiro Kawashima, Rika Sakai, Arata Ishii, Makoto Onizuka, Tomonari Takemura, Seitaro Terakura, Hiroatsu Iida, Mika Nakamae, Kohei Higuchi, Shinobu Tamura, Satoshi Yoshioka, Kazuto Togitani, Noriaki Kawano, Ritsuro Suzuki, Junji Suzumiya, Koji Izutsu, Takanori Teshima, Takahiro Fukuda

An analysis of oral microbial flora by T-RFLP in patients undergoing hematopoietic stem cell transplantation

  • Original Article

Miho Takahashi, Masako Toyosaki, Keiko Matsui, Shinichiro Machida, Eri Kikkawa, Yoshihide Ota, Akihiro Kaneko, Yoshiaki Ogawa, Kiyoshi Ando, Makoto Onizuka

Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy

  • Original Article

Ken Sagou, Nobuaki Fukushima, Shun Ukai, Miyo Goto, Kazutaka Ozeki, Akio Kohno

Functional analysis of a novel fusion protein PAX5-KIDINS220 identified in a pediatric Ph-like ALL patient

  • Original Article

Takuyo Kanayama, Toshihiko Imamura, Azusa Mayumi, Emi Soma, Kenichi Sakamoto, Fumihiko Hayakawa, Akihiko Tanizawa, Nobutaka Kiyokawa, Hajime Hosoi

FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group

  • Original Article

Tadashi Kumamoto, Hiroaki Goto, Chitose Ogawa, Toshinori Hori, Takao Deguchi, Takuya Araki, Akiko M. Saito, Atsushi Manabe, Keizo Horibe, Hidemi Toyoda

Myelodysplastic syndromes in a pediatric patient with Cri du Chat syndrome with a ring chromosome 5

  • Case Report

Akifumi Nozawa, Michio Ozeki, Shiho Yasue, Saori Endo, Tomonori Kadowaki, Hidenori Ohnishi, Hideki Muramatsu, Asahito Hama, Yoshiyuki Takahashi, Seiji Kojima, Toshiyuki Fukao

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders

  • Case Report

Sandra Sanchez, Luis Veloza, Luojun Wang, Mónica López, Armando López-Guillermo, Marta Marginet, Antonio Martínez, Olga Balagué, Elias Campo

Diagnosis of a difficult to differentiate case of early-onset hyperviscosity syndrome caused by IgM type multiple myeloma: a case report

  • Case Report

Takuro Yoshimura, Yoshiki Hayashi, Katsujun Shimizu, Naoko Yagi, Minako Tsutsumi, Yosuke Nakaya, Hoyuri Fuseya, Mirei Horiuchi, Masahiro Yoshida, Takafumi Nakao, Takeshi Inoue, Takahisa Yamane

Severe immune thrombocytopenic purpura in critical COVID-19

Valérie Lévesque, Émilie Millaire, Daniel Corsilli, Benjamin Rioux-Massé, François-Martin Carrier

A case of human herpesvirus 6 encephalitis following pediatric hematopoietic stem cell transplantation: early diagnosis and treatment matters

  • Case Report

Atsushi Sakamoto, Masaki Yamada, Shin-ichi Tsujimoto, Tomoo Osumi, Katsuhiro Arai, Daisuke Tomizawa, Akira Ishiguro, Kimikazu Matsumoto, Ken-Ichi Imadome, Motohiro Kato

Seroprevalence of Toxoplasma gondii among Japanese adults with hematological diseases

  • Letter to the Editor

Takehiko Mori, Kei Mikita, Yuya Koda, Masatoshi Sakurai, Masuho Saburi, Naoki Hasegawa, Jun Kato

Neu im Fachgebiet Onkologie

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.